Bruker Historical Balance Sheet

BRKR Stock

USD 58.90 1.83 3.21%

Trend analysis of Bruker balance sheet accounts such as Total Stockholder Equity of 1.4 B, Non Current Assets Total of 2.2 B or Non Currrent Assets Other of 184.5 M provides information on Bruker's total assets, liabilities, and equity, which is the actual value of Bruker to its prevalent stockholders. By breaking down trends over time using Bruker balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bruker latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bruker is a good buy for the upcoming year.

Bruker Inventory

1.02 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

About Bruker Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bruker at a specified time, usually calculated after every quarter, six months, or one year. Bruker Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bruker and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bruker currently owns. An asset can also be divided into two categories, current and non-current.

Bruker Balance Sheet Chart

At this time, Bruker's Total Liabilities is relatively stable compared to the past year. As of 11/26/2024, Short and Long Term Debt Total is likely to grow to about 1.4 B, though Other Stockholder Equity is likely to grow to (906.6 M).

Total Assets Total Stockholder Equity Non Current Assets Total Other Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Bruker assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bruker books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Bruker's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Total Liabilities is relatively stable compared to the past year. As of 11/26/2024, Short and Long Term Debt Total is likely to grow to about 1.4 B, though Other Stockholder Equity is likely to grow to (906.6 M).

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	1.1B	1.1B	1.4B	1.4B
Total Assets	3.7B	3.6B	4.2B	4.5B

Total Stockholder Equity Total Assets

Bruker balance sheet Correlations

	Total Assets	Total Stockholder Equity	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.97	0.96	0.42	0.85	0.34	0.96	-0.9	0.99	0.96	0.42	0.95	0.96	0.85	0.97	0.53	0.65	0.58	0.95	0.55	0.95	0.14	0.85	0.76	0.26	0.22
Total Stockholder Equity	0.97		0.92	0.38	0.75	0.49	0.88	-0.81	0.94	0.87	0.49	0.95	0.94	0.78	0.93	0.5	0.57	0.52	0.95	0.66	0.96	0.13	0.84	0.73	0.23	0.33
Non Current Assets Total	0.96	0.92		0.55	0.91	0.14	0.92	-0.95	0.95	0.94	0.34	0.91	0.98	0.95	0.98	0.53	0.44	0.35	0.95	0.37	0.91	0.01	0.95	0.57	0.26	0.14
Non Currrent Assets Other	0.42	0.38	0.55		0.51	-0.24	0.38	-0.45	0.42	0.44	-0.39	0.46	0.54	0.6	0.46	0.22	-0.05	-0.07	0.33	-0.1	0.39	-0.06	0.73	-0.04	0.28	-0.2
Other Assets	0.85	0.75	0.91	0.51		-0.11	0.9	-0.96	0.88	0.91	0.24	0.75	0.86	0.92	0.92	0.4	0.44	0.38	0.79	0.14	0.74	-0.13	0.83	0.49	0.26	-0.12
Common Stock Shares Outstanding	0.34	0.49	0.14	-0.24	-0.11		0.16	0.04	0.27	0.13	0.42	0.44	0.27	-0.07	0.19	0.3	0.34	0.41	0.35	0.93	0.46	0.48	0.1	0.56	0.07	0.53
Non Current Liabilities Total	0.96	0.88	0.92	0.38	0.9	0.16		-0.94	0.98	0.99	0.42	0.84	0.9	0.84	0.96	0.43	0.72	0.66	0.88	0.39	0.84	0.06	0.78	0.75	0.26	0.17
Other Stockholder Equity	-0.9	-0.81	-0.95	-0.45	-0.96	0.04	-0.94		-0.92	-0.94	-0.35	-0.79	-0.89	-0.93	-0.96	-0.45	-0.5	-0.42	-0.87	-0.23	-0.79	0.08	-0.83	-0.58	-0.34	-0.08
Total Liab	0.99	0.94	0.95	0.42	0.88	0.27	0.98	-0.92		0.98	0.39	0.93	0.95	0.86	0.97	0.54	0.67	0.61	0.93	0.49	0.93	0.14	0.84	0.76	0.26	0.17
Short Long Term Debt Total	0.96	0.87	0.94	0.44	0.91	0.13	0.99	-0.94	0.98		0.35	0.87	0.92	0.87	0.95	0.49	0.69	0.61	0.89	0.36	0.86	0.07	0.82	0.72	0.25	0.09
Other Current Liab	0.42	0.49	0.34	-0.39	0.24	0.42	0.42	-0.35	0.39	0.35		0.29	0.34	0.23	0.43	-0.19	0.38	0.38	0.51	0.5	0.38	-0.36	0.17	0.53	-0.02	0.48
Total Current Liabilities	0.95	0.95	0.91	0.46	0.75	0.44	0.84	-0.79	0.93	0.87	0.29		0.95	0.82	0.88	0.68	0.5	0.44	0.93	0.61	0.99	0.28	0.87	0.68	0.24	0.15
Property Plant And Equipment Net	0.96	0.94	0.98	0.54	0.86	0.27	0.9	-0.89	0.95	0.92	0.34	0.95		0.91	0.95	0.54	0.46	0.38	0.94	0.47	0.96	0.08	0.95	0.61	0.26	0.15
Net Debt	0.85	0.78	0.95	0.6	0.92	-0.07	0.84	-0.93	0.86	0.87	0.23	0.82	0.91		0.91	0.51	0.26	0.18	0.87	0.17	0.8	-0.1	0.94	0.39	0.3	-0.05
Retained Earnings	0.97	0.93	0.98	0.46	0.92	0.19	0.96	-0.96	0.97	0.95	0.43	0.88	0.95	0.91		0.46	0.54	0.49	0.94	0.42	0.88	-0.01	0.88	0.65	0.3	0.2
Accounts Payable	0.53	0.5	0.53	0.22	0.4	0.3	0.43	-0.45	0.54	0.49	-0.19	0.68	0.54	0.51	0.46		0.21	0.12	0.57	0.4	0.63	0.74	0.5	0.36	0.23	0.11
Cash	0.65	0.57	0.44	-0.05	0.44	0.34	0.72	-0.5	0.67	0.69	0.38	0.5	0.46	0.26	0.54	0.21		0.96	0.47	0.48	0.51	0.28	0.21	0.9	0.06	0.26
Cash And Short Term Investments	0.58	0.52	0.35	-0.07	0.38	0.41	0.66	-0.42	0.61	0.61	0.38	0.44	0.38	0.18	0.49	0.12	0.96		0.39	0.52	0.43	0.24	0.14	0.87	0.09	0.21
Net Receivables	0.95	0.95	0.95	0.33	0.79	0.35	0.88	-0.87	0.93	0.89	0.51	0.93	0.94	0.87	0.94	0.57	0.47	0.39		0.55	0.95	0.08	0.86	0.66	0.29	0.26
Common Stock Total Equity	0.55	0.66	0.37	-0.1	0.14	0.93	0.39	-0.23	0.49	0.36	0.5	0.61	0.47	0.17	0.42	0.4	0.48	0.52	0.55		0.63	0.42	0.3	0.76	0.16	0.59
Inventory	0.95	0.96	0.91	0.39	0.74	0.46	0.84	-0.79	0.93	0.86	0.38	0.99	0.96	0.8	0.88	0.63	0.51	0.43	0.95	0.63		0.23	0.86	0.69	0.24	0.21
Other Current Assets	0.14	0.13	0.01	-0.06	-0.13	0.48	0.06	0.08	0.14	0.07	-0.36	0.28	0.08	-0.1	-0.01	0.74	0.28	0.24	0.08	0.42	0.23		-0.03	0.29	0.11	0.28
Property Plant And Equipment Gross	0.85	0.84	0.95	0.73	0.83	0.1	0.78	-0.83	0.84	0.82	0.17	0.87	0.95	0.94	0.88	0.5	0.21	0.14	0.86	0.3	0.86	-0.03		0.38	0.29	0.04
Total Current Assets	0.76	0.73	0.57	-0.04	0.49	0.56	0.75	-0.58	0.76	0.72	0.53	0.68	0.61	0.39	0.65	0.36	0.9	0.87	0.66	0.76	0.69	0.29	0.38		0.14	0.38
Short Term Debt	0.26	0.23	0.26	0.28	0.26	0.07	0.26	-0.34	0.26	0.25	-0.02	0.24	0.26	0.3	0.3	0.23	0.06	0.09	0.29	0.16	0.24	0.11	0.29	0.14		-0.01
Intangible Assets	0.22	0.33	0.14	-0.2	-0.12	0.53	0.17	-0.08	0.17	0.09	0.48	0.15	0.15	-0.05	0.2	0.11	0.26	0.21	0.26	0.59	0.21	0.28	0.04	0.38	-0.01

Click cells to compare fundamentals

Bruker Account Relationship Matchups

Bruker balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.8B	3.0B	3.7B	3.6B	4.2B	4.5B
Total Stockholder Equity	917.1M	975.6M	1.1B	1.1B	1.4B	1.4B
Non Current Assets Total	975.2M	1.1B	1.2B	1.5B	2.1B	2.2B
Non Currrent Assets Other	16.8M	39.6M	70.8M	(99.8M)	175.7M	184.5M
Other Assets	77.3M	180M	160.9M	208.9M	240.2M	252.2M
Common Stock Shares Outstanding	156.6M	154.6M	152.9M	149.4M	147.2M	143.8M
Liabilities And Stockholders Equity	2.8B	3.0B	3.7B	3.6B	4.2B	4.5B
Non Current Liabilities Total	1.2B	1.3B	1.6B	1.6B	1.6B	1.7B
Other Stockholder Equity	(333.8M)	(450.7M)	(582.5M)	(828.7M)	(954.3M)	(906.6M)
Total Liab	1.9B	2.1B	2.6B	2.5B	2.8B	3.0B
Short Long Term Debt Total	860.3M	891.5M	1.3B	1.2B	1.4B	1.4B
Other Current Liab	388.8M	210.1M	234.4M	596.8M	316.2M	237.4M
Total Current Liabilities	645.6M	793.6M	938.5M	913.8M	1.2B	1.3B
Property Plant And Equipment Net	371.7M	462.9M	406.1M	487M	691.4M	726.0M
Net Debt	182M	209.7M	266M	573.7M	891.3M	935.9M
Retained Earnings	1.3B	1.4B	1.7B	1.9B	2.3B	2.4B
Accounts Payable	118.4M	134.6M	147.4M	178.4M	202.7M	212.8M
Cash	678.3M	681.8M	1.1B	645.5M	488.3M	311.3M
Cash And Short Term Investments	684.9M	731.8M	1.2B	645.5M	488.3M	358.2M
Net Receivables	362.2M	335.3M	416.9M	595.3M	621.8M	652.9M
Inventory	577.2M	692.3M	710.1M	803.7M	968.3M	1.0B
Other Current Assets	172M	165.6M	176.6M	72.3M	85.8M	108.0M
Property Plant And Equipment Gross	371.7M	462.9M	406.1M	487M	1.2B	1.3B
Total Current Assets	1.8B	1.9B	2.5B	2.1B	2.2B	1.1B
Accumulated Other Comprehensive Income	(25.5M)	3.7M	(8.2M)	14.8M	6M	5.7M
Short Term Debt	500K	23.5M	130.3M	35.1M	144.5M	151.7M
Intangible Assets	603.5M	229.1M	211.8M	270.9M	330.5M	196.5M
Other Liab	311M	389.4M	404.9M	318.2M	365.9M	384.2M
Long Term Debt	812.8M	842.3M	1.2B	1.2B	1.2B	1.2B
Short Term Investments	0.0	6.6M	50M	100M	12M	11.4M
Property Plant Equipment	306.1M	395.5M	406.1M	487M	560.1M	588.1M
Current Deferred Revenue	137.9M	189.2M	197.5M	225.7M	400M	420M
Treasury Stock	(543.8M)	(667M)	(820.3M)	(1.1B)	(976.5M)	(927.7M)
Good Will	293M	320.4M	339.5M	457.6M	582.6M	611.7M
Net Tangible Assets	491.5M	509.6M	312.5M	1.2B	1.4B	1.5B
Noncontrolling Interest In Consolidated Entity	10.3M	13.1M	14.1M	11.9M	13.7M	8.2M
Retained Earnings Total Equity	1.3B	1.4B	1.7B	1.9B	2.2B	2.3B
Long Term Debt Total	812.8M	842.3M	1.2B	1.2B	1.4B	1.4B

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

0.87	A	Agilent Technologies	Pair Corr
0.89	ME	23Andme Holding	Pair Corr
0.61	VALN	Valneva SE ADR	Pair Corr

Moving against Bruker Stock

0.8	EXEL	Exelixis	Pair Corr
0.75	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.56	EWTX	Edgewise Therapeutics	Pair Corr
0.45	KTTAW	Pasithea Therapeutics	Pair Corr

The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.

The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Bruker Stock Analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bruker Historical Balance Sheet

Bruker Inventory

1.02 Billion

About Bruker Balance Sheet Analysis

Bruker Balance Sheet Chart

Total Assets

Total Stockholder Equity

Non Current Assets Total

Bruker balance sheet Correlations

Bruker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bruker balance sheet Accounts

Pair Trading with Bruker

Moving together with Bruker Stock

Moving against Bruker Stock

Additional Tools for Bruker Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Assets
Short Long Term Debt Total	+ 0.99	Non Current Liabilities Total
Inventory	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.98	Non Current Assets Total
Retained Earnings	+ 0.98	Non Current Assets Total
Total Liab	+ 0.98	Non Current Liabilities Total

Retained Earnings	- 0.96	Other Stockholder Equity
Other Stockholder Equity	- 0.96	Other Assets
Other Stockholder Equity	- 0.95	Non Current Assets Total
Short Long Term Debt Total	- 0.94	Other Stockholder Equity
Other Stockholder Equity	- 0.94	Non Current Liabilities Total
Net Debt	- 0.93	Other Stockholder Equity